Shoulder Innovation's InSet reverse shoulder arthroplasty system received FDA 510(k) clearance, the company said Aug. 23.
The system uses artificial intelligence for preoperative planning. Instrumentation for six different products is integrated into one tray, making the system optimal for outpatient settings. It's reportedly the only true fully convertible humeral inlay system.
"Not only does our system provide a reduced implant and instrument footprint, but more importantly, the surgeon has access to our primary total shoulder and reverse shoulder including our innovative primary InSet and InSet Plus glenoid technology all in one place," Chief Commercialization Officer David Blue said. "This convertible system is game-changing and efficient. The InSet Platform simplifies shoulder replacement technology in order to improve outcomes."